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Sequence Analysis and Characterization of a Transferable Hybrid Plasmid
Encoding Multidrug Resistance and Enabling Zoonotic Potential for
Extraintestinal Escherichia coli
Abstract
ColV plasmids of extraintestinal pathogenic Escherichia coli (ExPEC) encode a variety of fitness and virulence
factors and have long been associated with septicemia and avian colibacillosis. These plasmids are found
significantly more often in ExPEC, including ExPEC associated with human neonatal meningitis and avian
colibacillosis, than in commensal E. coli. Here we describe pAPEC-O103-ColBM, a hybrid RepFIIA/FIB
plasmid harboring components of the ColV pathogenicity island and a multidrug resistance (MDR)-encoding
island. This plasmid is mobilizable and confers the ability to cause septicemia in chickens, the ability to cause
bacteremia resulting in meningitis in the rat model of human disease, and the ability to resist the killing effects
of multiple antimicrobial agents and human serum. The results of a sequence analysis of this and other ColV
plasmids supported previous findings which indicated that these plasmid types arose from a RepFIIA/FIB
plasmid backbone on multiple occasions. Comparisons of pAPEC-O103-ColBM with other sequenced ColV
and ColBM plasmids indicated that there is a core repertoire of virulence genes that might contribute to the
ability of some ExPEC strains to cause high-level bacteremia and meningitis in a rat model. Examination of a
neonatal meningitis E. coli(NMEC) population revealed that approximately 58% of the isolates examined
harbored ColV-type plasmids and that 26% of these plasmids had genetic contents similar to that of pAPEC-
O103-ColBM. The linkage of the ability to confer MDR and the ability contribute to multiple forms of human
and animal disease on a single plasmid presents further challenges for preventing and treating ExPEC
infections.
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ColV plasmids of extraintestinal pathogenic Escherichia coli (ExPEC) encode a variety of fitness and
virulence factors and have long been associated with septicemia and avian colibacillosis. These plasmids are
found significantly more often in ExPEC, including ExPEC associated with human neonatal meningitis and
avian colibacillosis, than in commensal E. coli. Here we describe pAPEC-O103-ColBM, a hybrid RepFIIA/FIB
plasmid harboring components of the ColV pathogenicity island and a multidrug resistance (MDR)-encoding
island. This plasmid is mobilizable and confers the ability to cause septicemia in chickens, the ability to cause
bacteremia resulting in meningitis in the rat model of human disease, and the ability to resist the killing effects
of multiple antimicrobial agents and human serum. The results of a sequence analysis of this and other ColV
plasmids supported previous findings which indicated that these plasmid types arose from a RepFIIA/FIB
plasmid backbone on multiple occasions. Comparisons of pAPEC-O103-ColBM with other sequenced ColV and
ColBM plasmids indicated that there is a core repertoire of virulence genes that might contribute to the ability
of some ExPEC strains to cause high-level bacteremia and meningitis in a rat model. Examination of a
neonatal meningitis E. coli (NMEC) population revealed that approximately 58% of the isolates examined
harbored ColV-type plasmids and that 26% of these plasmids had genetic contents similar to that of pAPEC-
O103-ColBM. The linkage of the ability to confer MDR and the ability contribute to multiple forms of human
and animal disease on a single plasmid presents further challenges for preventing and treating ExPEC
infections.
ColV plasmids have a long history in scientific literature
describing their association with the virulence of extraintestinal
pathogenic Escherichia coli (ExPEC) (58). The first completed
ColV plasmid sequence (24) localized the genes encoding the
virulence traits to a 94-kb pathogenicity-associated island
(PAI). Gene prevalence studies involving the genes in this PAI
confirmed the hypothesis of Waters and Crosa that there are
“constant” and “variable” portions of the ColV PAI and that
the constant region contains the RepFIB and aerobactin oper-
ons (58). Since those studies, several more of these plasmids
have been sequenced, including a plasmid variant known as
ColBM, which is closely related to ColV plasmids, containing
remnants of the ColV operon and the ColV PAI in a very
similar arrangement (23). ColV and ColBM plasmids have
been found to occur significantly more often in ExPEC than in
commensal E. coli. Furthermore, recent work suggests that
some ExPEC subpathotypes, including avian pathogenic E. coli
(APEC) and human neonatal meningitis E. coli (NMEC), har-
bor these plasmids more often than other subpathotypes (10,
24, 26, 35, 42). Interestingly, although these plasmids are very
prevalent in NMEC populations, the most-studied NMEC iso-
lates appear to lack these plasmids (31, 61). Thus, far, it has
been shown that ColV and ColBM plasmids contribute to E.
coli’s growth in human urine, its ability to cause a murine
urinary tract infection (UTI), and its ability to contribute to
septicemia and avian colibacillosis (1, 2, 49, 50, 60). Certain
genes in the ColV plasmid PAI are upregulated greatly during
avian infection and during growth in human urine (49), and
certain genetic regions of the ColV plasmids have been asso-
ciated with avian disease (57), further suggesting that the ColV
and ColBM plasmids have a role in the pathogenesis of avian
colibacillosis and UTI. However, despite the large number of
phenotypic properties attributed to these plasmids, the under-
lying molecular mechanisms of these traits and the overall
molecular biology of the ColV plasmid are not completely
understood.
There is great concern about the possible emergence of
multidrug-resistant bacteria. This is particularly true of the
bacteria inhabiting production animals, in which antibiotics are
routinely used as growth-promoting and therapeutic agents
(47). Of particular interest are transmissible plasmids that, in a
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singe transfer event, are able to cause a major shift in the
bacterial population dynamics by conferring resistance to mul-
tiple antimicrobial agents. Other types of virulence plasmids
have been shown to encode multidrug resistance (MDR), but
this has not been observed for ColV and ColBM plasmids
previously. The initial aims of this study were to determine if
naturally occurring plasmids containing the ColV PAI and an
MDR-encoding island could be identified. Once a representa-
tive plasmid was identified, we sequenced and analyzed this
plasmid to determine its roles in virulence and drug resistance
and to determine if such plasmids present a risk to human and
animal health. Here we describe this plasmid and the traits that
it confers.
MATERIALS AND METHODS
Bacterial strains and plasmids. All strains used in this study are listed in Table
1. Plasmid pAPEC-O103-ColBM was originally derived from ExPEC strain 408,
which was isolated from a commercial laying hen with peritonitis. This strain was
identified because it harbored a single large plasmid and contained both ColV
plasmid virulence-associated genes and class 1 integron-associated genes. ExPEC
408 is a member of the O103 serogroup and B1 phylogenetic group (42). This
strain was cured of pAPEC-O103-ColBM by repeated passage in overnight
cultures grown in LB broth with shaking at 37°C. After overnight passage, replica
plating was used to select for loss of plasmid-mediated resistance to streptomycin
at a concentration of 50 g/ml. pAPEC-O103-ColBM was reintroduced into the
plasmid-cured derivative using electroporation (46). For ColV and ColBM gene
prevalence studies, a total of 283 isolates were used, including 96 isolates from
cases of human UTI, 96 E. coli isolates implicated in avian colisepticemia, and 91
isolates from cases of human neonatal meningitis. APEC isolates were obtained
from lesion sites in chickens and turkeys raised for meat consumption and laying
hens from commercial farms throughout the United States (42, 43). Seventy of
the NMEC strains were obtained from the cerebrospinal fluid (CSF) of newborns
in the Netherlands and were isolated from 1989 through 1997 (21, 26). The
remaining NMEC isolates were isolated in a similar way in a similar time period
from patients in the United States. The uropathogenic E. coli (UPEC) isolates
were obtained from MeritCare Medical Center in Fargo, ND (43). These isolates
were obtained from urine of patients who were different ages and sexes and had
uncomplicated UTI.
Plasmid isolation. ExPEC strain 408’s plasmid DNA was isolated using a
Qiagen midi plasmid kit and a modified procedure optimized for bacterial arti-
ficial chromosome (BAC) isolation (Qiagen). A single colony was inoculated into
100 ml of LB broth and grown overnight at 37°C with shaking. After purification,
plasmid DNA was precipitated twice with 3 volumes of 100% ethanol, washed
twice with 70% ethanol, and resuspended in sterile water.
Shotgun library construction and sequencing. A random shotgun library of
pAPEC-O103-ColBM was prepared from purified plasmid DNA. DNA was
sheared, concentrated, desalted, end repaired, tailed, and size fractionated by
electrophoresis. The 1.5- to 2.5-kb fraction was isolated and purified using stan-
dard methods prior to cloning into pWRIGHT. Shotgun sequencing was per-
formed by Seqwright, Inc. (Houston, TX). The data were collected with ABI
3700 and ABI 3730xl capillary sequencers.
Assembly and annotation. Sequencing reads were assembled using SeqMan
software from DNASTAR (Madison, WI). Gap closure for pAPEC-O103-
ColBM was accomplished using the pooled primer technique described by Tet-
telin et al. (56). Open reading frames (ORFs) in the plasmid sequence were
identified using GeneQuest from DNASTAR (Madison, WI), followed by man-
ual inspection, as previously described (23).
Comparative genomics. Nucleotide similarities to previously described ColV
and ColBM sequences were determined using a local standalone BLAST analysis
(3). Protein alignment and nucleotide alignment were performed using the ClustalW
algorithm in the DNASTAR package (LaserGene). A circular map was constructed
using GenVision (LaserGene).
Conjugation assay. The transmissibility of pAPEC-O103-ColBM was assessed
by performing a liquid conjugation experiment (28). Briefly, 0.2 ml of donor cells
in exponential growth phase was mixed with 1.8 ml of an overnight culture of
recipient cells in Antibiotic 3 broth (Difco Laboratories). Mixtures were incu-
bated overnight without shaking at 25°C, 37°C, and 42°C. Transconjugants were
selected on LB agar containing a donor-inhibiting concentration of nalidixic acid
(30 g/ml) and a recipient-inhibiting concentration of streptomycin (50 g/ml).
Triparental mating assay. Because pAPEC-O103-ColBM was found to be
non-self-transmissible, triparental mating was performed using helper plasmid
pRK2013 in an effort to mobilize pAPEC-O103-ColBM into E. coli DH5 (13).
The donor, recipient, and helper strains were grown to mid-logarithmic phase
and then spotted either together or separately on LB agar plates and incubated
overnight. The spots were then restreaked on selective agar containing 30 g/ml
nalidixic acid and 50 g/ml streptomycin. Replica plating on agar containing 50
g/ml kanamycin was used to verify the absence of pRK2013.
Phylogenetic typing and virulence genotyping. Isolates were assigned to phy-
logenetic groups using the method of Clermont et al. (6). Using this method,
isolates were assigned to one of four groups (group A, B1, B2, or D) based on the
presence of two genes (chuA and yjaA) and a DNA fragment (TSPE4.C2) as
determined by PCR. Boiled lysates of overnight cultures were used as a source
of template DNA for this study (20). Amplification was performed with a 25-l
reaction mixture as previously described (43).
Multiplex PCR was performed to determine the presence of 49 genes or traits.
Some of the multiplex panels used have been described previously (23, 24, 42,
43). The experiments included positive- and negative-control organisms. All
primers were obtained from Integrated DNA Technologies (Coralville, IA).
Strains known to possess or lack the genes of interest were examined with each
amplification procedure. Experiments were performed twice. An isolate was
considered to contain a gene of interest if it produced an amplicon of the
expected size.
PFGE. ExPEC strain 408 and its derivatives were subtyped by pulsed-field gel
electrophoresis (PFGE) using the PulseNet 1-day (24- to 28-h) standardized
laboratory protocol described by Ribot et al. (41). Salmonella enterica serovar
Branderup H9812 (ATCC BAA-664) was used as the size standard. Restriction
was carried out using XbaI (Invitrogen). DNA macrorestriction fragments were
resolved on 1% SeaKem Gold agarose (Cambrex Bio Science Inc., Rockland,
ME) in 0.5 Tris-borate-EDTA. PFGE was carried out as previously described
(11, 53). Images were captured using a UV imager (Alpha Innotech, CA) and
stored as .tif files.
Antimicrobial susceptibility. ExPEC 408 and its derivatives were examined to
determine their antimicrobial susceptibilities using the Sensititre CMV1AGNF
plate-SIW 2004 panel (Trek Diagnostics) according to Food and Drug Admin-
istration (FDA) and Clinical Laboratory Standards Institute (CLSI) (formerly
NCCLS) recommendations. A 96-well microtiter plate was used to test the
susceptibilities of strains to 15 different antimicrobials commonly associated with
animal and human health. The antimicrobials used were amikacin (0.5 to 64
g/ml), amoxicillin-clavulanic acid (0.25 to 64 g/ml), ampicillin (1 to 32 g/ml),
cefoxitin (0.5 to 32 g/ml), ceftiofur (0.12 to 8 g/ml), ceftriaxone (0.25 to 64
g/ml), chloramphenicol (2 to 32 g/ml), ciprofloxacin (0.015 to 4 g/ml), gen-
tamicin (0.25 to 16 g/ml), kanamycin (8 to 64 g/ml), nalidixic acid (0.5 to 32
g/ml), streptomycin (32 to 64 g/ml), sulfisoxazole (16 to 512 g/ml), tetracy-
cline (4 to 32 g/ml), and trimethoprim (0.12 to 4 g/ml)-sulfamethoxazole (2.38
to 76 g/ml). The panels were inoculated according to the manufacturer’s in-
structions (Trek Diagnostics). Isolates were defined as susceptible or resistant by
comparison to FDA- and NCCLS-recommended breakpoints for each antimi-
crobial agent, where the breakpoint is the minimum drug concentration above
which growth of an isolate should occur. Additionally, disk diffusion was used to
determine the susceptibilities of isolates to the following drugs: streptomycin,
TABLE 1. Bacterial strains and plasmids used in this study
E. coli strain or plasmid Description
Strains
408..............................................Wild-type ExPEC containing
pAPEC-O103-ColBM
408.1...........................................Plasmid-cured derivative of ExPEC
408
408.2...........................................Plasmid-complemented derivative of
ExPEC 408.1
408.3...........................................DH5 containing pAPEC-O103-
ColBM
DH5 .........................................Avirulent recipient strain
NMEC RS218...........................Wild-type NMEC positive control
APEC O1 ..................................Wild-type APEC positive control
Plasmids
pAPEC-O103-ColBM ..............ColBM virulence plasmid
pRK2013....................................Mobilization helper plasmid
1932 JOHNSON ET AL. INFECT. IMMUN.
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tetracycline, chloramphenicol, gentamicin, trimethoprim, ampicillin, nalidixic
acid, kanamycin, sulfisoxazole, rifampin, and erythromycin.
In vitro bacterial growth assays. The abilities of ExPEC 408 and its derivatives
to grow in LB broth were compared. Strains were grown overnight in 2 ml of LB
broth. The next day, cell densities were calculated using spectrophotometry, and
cultures were diluted in fresh LB broth to obtain a starting optical density at 600 nm
(OD600) of 0.05. Cultures were incubated at 37°C with shaking in a SpectraMax
Plus384 spectrophotometer. Samples were taken every 15 min for 18 h. The results
shown are the averages of two independent trials with four replicates each. In
all of the growth assays described here, the size of the inoculum was limited
to less than 5% of the total volume to limit dilution of the growth medium
used. Viable counts were also determined by performing the same assay with
2 ml of LB broth, followed by plating of serial dilutions each hour on
MacConkey agar.
Strains were also assessed to determine their abilities to survive in filtered
chicken serum and filtered human serum. Strains were first grown overnight in 2
ml of LB broth. The next day, cell densities were calculated using spectropho-
tometry, and the cultures were washed in phosphate-buffered saline (PBS) and
diluted in LB broth with 100% chicken serum or 50% human serum to obtain a
starting OD600 of 0.05. The cultures were incubated at 37°C with shaking in a
SpectraMax Plus384 spectrophotometer. Samples were taken every 15 min for
18 h. The results shown are the averages of two independent trials with four
replicates each. Viable counts were also determined by performing the same
assays with 2 ml of 100% chicken serum, 90% human serum, or 75% human
serum, followed by plating of serial dilutions each hour on MacConkey agar.
Strains were also assessed to determine their abilities to grow in LB broth
containing the iron chelator 2,2-dipyridyl (38). Strains were first grown over-
night in 2 ml of LB broth. The next day, cell densities were calculated using
spectrophotometry, the cultures were washed in PBS, and pellets were diluted in
LB broth with 400 M 2,2-dipyridyl to obtain a starting OD600 of 0.05. The
cultures were incubated at 37°C with shaking in a SpectraMax Plus384 spectro-
photometer. Samples were taken every 15 min for 18 h. The results shown are the
averages of two independent trials with four replicates each. Viable counts were
also determined by performing the same assay with 2 ml of LB broth containing
2,2-dipyridyl, followed by plating of serial dilutions each hour on MacConkey
agar.
Strains were also assessed to determine their abilities to grow in human urine.
The assay was performed as described elsewhere (45). Only urine from healthy,
antibiotic-free volunteers who reported that they never had had a UTI was used
for this study. Prior to the study, urine from five volunteers was collected,
individually filter sterilized with 0.2-m filters, pooled, and stored at 20°C. On
the day before the assay was performed, the strains tested were grown overnight
in 2 ml of LB broth (52). The next day, the cell densities were estimated using
spectrophotometry, and cultures were diluted in PBS prior to inoculation into
urine to obtain a starting OD600 of approximately 0.05. The cultures were incu-
bated at 37°C with shaking in a SpectraMax Plus384 spectrophotometer. Samples
were taken every 15 min for 18 h. The results shown are the averages of two
independent trials with four replicates each. Viable counts were also determined
by performing the same assay with 2 ml of urine, followed by plating of serial
dilutions each hour on MacConkey agar.
Rat model of human bacteremia and neonatal meningitis. All animal exper-
iments were performed in accordance with the institutional guidelines for the
ethical treatment of animals at Iowa State University. ExPEC 408 and its plas-
mid-cured and complemented derivatives were assessed to determine their abil-
ities to induce septicemia and meningitis in 5-day-old rats, as previously de-
scribed (17). Each experimental group contained at least 20 rats, and each
experiment was performed twice on separate occasions. Briefly, specific-patho-
gen-free Sprague-Dawley rats were inoculated via intraperitoneal injection when
they were 5 days old with 200 CFU of each bacterial strain suspended in PBS. At
18 h postinoculation, 25 l of blood was drawn from each rat and plated on
MacConkey agar to determine the concentration of the strain in the blood. Rats
were subsequently euthanized, and 10 l of cerebrospinal fluid (CSF) was re-
moved via cisternal puncture and plated on MacConkey agar to determine the
concentration of each strain in the CSF. Brain tissues were also collected for
histopathology.
Models of avian colibacillosis. ExPEC 408 and its derivatives were assessed to
determine their abilities to cause avian colibacillosis using broiler chicks, as
described previously (29, 30). One-day-old chicks that were vaccinated only
against Marek’s disease were obtained from a commercial source, were divided
into groups containing 10 chicks, and were placed in Horsfall units or in separate
rooms. The chicks were given food and water ad libitum. For intratracheal
inoculation, chicks were inoculated with 0.1 ml of a bacterial suspension con-
taining 108 CFU/ml of bacteria or with 0.1 ml of PBS directly in the trachea. For
subcutaneous inoculation, birds were injected with 0.1 ml of a bacterial suspen-
sion containing 107 CFU/ml of bacteria or with 0.1 ml of PBS in the back of the
neck. Chicks were challenged on the day that they were received, and they were
monitored for the first 6 h postchallenge on day 1 and then every 12 h for 7 days.
Deaths were recorded, and the survivors were euthanatized and examined for
macroscopic lesions. Strains were compared to the wild-type positive-control
strain APEC O1 (27) and the negative-control strain DH5. A lesion scoring
system was used as previously described (44). Each experiment was performed
twice on separate occasions.
E. coli adherence to and invasion of human BMECs. ExPEC 408 and its
derivatives were assessed to determine their abilities to adhere to and invade
human brain microvascular epithelial cells (BMECs), since these activities are a
prerequisite for penetration of E. coli into the central nervous system to cause
meningitis. The invasion assay was performed as described by Huang et al. (19).
Briefly, 2  106 mid-log-phase bacteria were added to confluent monolayers of
BMECs in 96-well microtiter plates, and the plates were centrifuged to synchro-
nize invasion. The plates were incubated for 90 min, the wells were washed, and
the cells were incubated in gentamicin-containing medium to kill bacteria that
were not internalized. BMECs were washed and lysed with Triton X-100. Ali-
quots of the lysate were diluted and plated to determine viable counts. The
results shown below are the averages of three replicates. The adhesion assay was
performed like the invasion assay, except that gentamicin was not used.
Statistics. All growth rate data were analyzed using linear regression analysis
(Systat, Evanston, IL) to determine the specific growth rate of each strain. A
Mann-Whitney U test was used to compare lesion scores obtained in the chick
experiments and bacterial counts obtained in the rat experiments. A two-tailed
Student t test was used to compare differences among the growth rates and
among the BMEC adherence and invasion data (51).
Nucleotide sequence accession number. The complete sequence and annota-
tion of pAPEC-O103-ColBM has been deposited in the GenBank database
under accession number CP001232.
RESULTS
Sequencing of pAPEC-O103-ColBM. A search of an ExPEC
collection consisting of over 1,000 isolates was performed in an
effort to identify candidate hybrid plasmids harboring both
ColV virulence-associated genes and an MDR-encoding is-
land. ExPEC strain 408, which was isolated from a laying hen
with peritonitis, was identified because it contained a single
plasmid harboring ColV-associated virulence genes and class
1 integron-associated genes. pAPEC-O103-ColBM was se-
quenced and analyzed because of the linkage of virulence and
MDR on the same plasmid. Draft sequencing, assembly, and
finishing were performed to obtain a single contiguous se-
quence with an average of 8-fold coverage spanning 124,705
bp. In this sequence, 137 ORFs that encoded sequences that
were more than 80 amino acids long were identified. pAPEC-
O103-ColBM can be divided into three functional modules
that are involved in virulence, transfer, and antimicrobial re-
sistance (Fig. 1). The virulence-associated module spanned
approximately 55,000 bp and closely resembled the virulence-
associated modules of other sequenced ColV plasmids (15, 23,
24, 34, 39). This region contained the previously described
“conserved region” of the ColV PAI encoding multiple iron
acquisition and transport systems (aerobactin, SitABCD, and
IroBCDEN), the RepFIB replicon, the hemolysin HlyF, and
the Iss protein involved in serum resistance (24). Like other
sequenced ColBM plasmids, this plasmid also had a colicin-
encoding region containing truncated portions of the ColV
operon along with the ColBM operon (23, 57). In its PAI,
however, was a 5,871-bp insertion between the sitABCD and
aerobactin operons (Fig. 2). This region appears to have been
acquired via a conjugative transposon, as it included a 70-bp
imperfect inverted repeat region and exhibited 92% nucleotide
VOL. 78, 2010 CHARACTERIZATION OF TRANSFERABLE HYBRID PLASMID 1933
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identity with the transposase sequence for Tn1000 (GenBank
accession no. AY598759). Additionally, this region contained
two coding regions whose predicted protein products exhibited
similarity with a manganese-dependent inorganic pyrophos-
phatase and a universal stress protein UspA homolog (Table
2). These products most closely match predicted proteins from
Citrobacter koseri strain ATCC BAA-895, whose genome is the
first sequenced genome of this bacterial species implicated in
human neonatal meningitis (9). Analysis of the predicted
UspA protein sequence revealed that it did not closely resem-
ble other chromosomally encoded UspA sequences of E. coli
strains. The uspA gene in the E. coli and Salmonella chromo-
somes has been recognized because of its roles in oxidative
stress resistance, iron scavenging, motility, and adhesion, all of
which are traits that are required in an extraintestinal pathogen
(36), and to our knowledge this uspA homolog is the only uspA
homolog introduced into a plasmid.
The transfer module of pAPEC-O103-ColBM spanned
about 10,000 bp and was not intact, containing only finO-
traXIDTSG. The traI gene in this truncated region was inter-
FIG. 1. Circular map of pAPEC-O103-ColBM. The outer two circles show predicted coding regions in forward and reverse orientations,
and different colors indicate different predicted functions. The next circle shows the GC content in a 1,000-bp window with 10-bp steps.
The next five circles show levels of nucleotide homology with other sequenced ColV-type plasmids. Blue indicates 90% homology with
pAPEC-O103-ColBM, while black indicates 90% homology. The numbers on these circles indicate comparisons with pAPEC-O2-ColV
(circle 1), pAPEC-O1-ColBM (circle 2), pVM01 (circle 3), pCVM29188_146 (circle 4), and pSMS-3-5_130 (circle 5). The map was created
using GenVision from DNASTAR.
1934 JOHNSON ET AL. INFECT. IMMUN.
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rupted by an IS26 element, and the traG gene was disrupted
and fused with a putative transposase element gene. This trun-
cation was reflected phenotypically by the inability of pAPEC-
O103-ColBM to self-transfer to E. coli DH5.
The MDR-encoding region of pAPEC-O103-ColBM spanned
approximately 35,000 bp and was between the RepFIIA and
RepFIB plasmid replicons. A detailed analysis of this region iden-
tified 10 resistance-associated elements (Fig. 3). The 5 end of
pAPEC-O103-ColBM’s MDR-encoding module contained a por-
tion of the transposon Tn1721, including tetAR and tnpA (8).
Downstream of this region was an approximately 22-kb region
flanked by 25-bp exact inverted repeats. This region contained the
sul2 and strAB genes at its 5 end, which encode sulfonamide and
streptomycin resistance, respectively. Immediately downstream of
strAB was a class 1 integron in an In2-like region that contained
dfrA1 in the gene cassette region encoding trimethoprim resis-
tance. This gene was in addition to the core class 1 integron genes
intI1, aadA1, qacE	1, and sulI (32). Downstream of the class 1
integron were other typical components of In2, including tniAB	
and the merEDACPTR genes encoding mercury resistance (32).
Unlike a typical In2 element, pAPEC-O103-ColBM contained an
insertion in the tniB	 gene, flanked by 12-bp exact inverted re-
peats, with homology to plasmid pTZ3721 in the GenBank data-
base sequence (Fig. 4) (37). This 6.5-kb region contained the
mphB gene encoding macrolide resistance and a gene exhibiting
homology to a putative penicillin binding protein gene (37).
pAPEC-O103-ColBM was compared to five other se-
quenced ColV and ColBM plasmids in an effort to better
understand the evolution of these plasmids (Fig. 1). The
plasmids examined were pAPEC-O1-ColBM (23), pAPEC-
O2-ColV (24), pCVM29188_146 (15), pSMS35_130 (14),
and pVM01 (57). Of the 137 predicted coding regions, 18
(13.1%) were shared by all 5 plasmids with a level of nucle-
otide similarity greater than 90%. The genes shared by all
plasmids included hlyF, sitABCD, repA (RepFIB), some
genes of the F transfer region, and a putative transcriptional
regulator gene. If not for pSMS35_130, which lacks much of
the ColV PAI, much more of this PAI, including the aer-
obactin and iroBCDEN operons and the iss gene, would be
conserved among all of the plasmids sequenced. Most of the
plasmids studied lacked the genes of the MDR-encoding
island; the exception was pSMS35_130, which contained a
portion of these resistance-associated genes. Overall, 43
(31.4%) of the pAPEC-O103-ColBM coding regions exam-
ined were not found in any other plasmid sequenced (Table
2). Among the predicted proteins were mobile genetic ele-
ments, replication proteins, resistance-associated proteins,
proteins of unknown function, and UspA.
We also examined the current ColV pangenome based on
the available plasmid sequences. The results demonstrated that
there is a high degree of diversity outside the “core” ColV
regions. In the six plasmids, 358 nonredundant ORFs were
identified. The “core” ORFs that apparently define the typical
ColV backbone include the F transfer region, portions of the
ColV operon, plasmid stability genes, the RepFIB replicon,
and the conserved portion of the ColV PAI. However, each
FIG. 2. Linear maps of sequenced ColV and ColBM plasmids. The bar at the top indicates positions (in base pairs). The maps begin with
RepFIIA and are drawn to scale. Virulence genes of interest are identified and indicated by different colors. The plasmids are ordered according
to evolutionary relationships of concatenated gene sequences (hlyF, traX, finO, repA, repA1). The evolutionary history was inferred using the
neighbor-joining method (54). Bootstrap consensus trees were inferred using 500 replicates. Bootstrap confidence values greater than 50% are
indicated at the nodes. The tree is drawn to scale based on evolutionary distances, and dotted lines extend the branches to the plasmid maps.
Distances were computed using the maximum composite likelihood method (scale bar 
 0.02 base substitution per site). Phylogenetic analyses
were conducted with MEGA4 (55).
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plasmid had its own set of unique ORFs, and the plasmids that
were the largest ColV plasmids sequenced, such as pAPEC-
O2-ColV, were the plasmids with the largest numbers of
unique ORFs. The ORFs were usually clusters of genes on a
plasmid surrounded by IS1 elements, suggesting that they
were acquired via homologous recombination. Multilocus
sequence analysis was performed using genetic regions conserved
in the 6 plasmids studied, including hlyF, finO, traX, repA1, and
repA (Fig. 2). This analysis suggested that the plasmids fell into
two lineages, a lineage containing pSMS35_130, pECOS88,
pCVM29188_146, and pAPEC-O2-ColV and a lineage contain-
ing pVM01, pAPEC-1, pAPEC-O1-ColBM, and pAPEC-O103-
ColBM.
Phenotypic characteristics of pAPEC-O103-ColBM. Liquid
conjugation assays in which we attempted to transfer pAPEC-
O103-ColBM into E. coli DH5 were not successful. This
plasmid was successfully mobilized into DH5, however, using
the helper plasmid pRK2013. pAPEC-O103-ColBM was also
successfully electroporated into DH5 using streptomycin as a
selectable marker. Serial passage successfully cured pAPEC-
O103-ColBM from its wild-type host, and subsequent plasmid
complementation via electroporation was successful (Table 1).
The donor and transconjugant strains were examined to deter-
mine the presence of 49 ExPEC-associated genes and the phy-
logenetic type using multiplex PCR. The transconjugants had
the expected gene profiles compared to the donor strain, Ex-
PEC 408 (data not shown); that is, the transconjugant strains
appeared to have acquired ColV plasmid-associated genes but
not to have acquired any chromosomal genes found in ExPEC
408. Additionally, all strains belonged to the B1 phylotype.
PFGE of these strains verified that they had identical chromo-
somal backgrounds, further suggesting that only the plasmid
DNA in each transconjugant had been altered (data not
shown).
ExPEC 408 and its cured and complemented derivatives
were tested to determine their abilities to grow in LB broth, LB
broth supplemented with 400 M 2,2-dipyridyl (an iron che-
TABLE 2. Predicted proteins unique to pAPEC-O103-ColBM
compared to other sequenced ColV-type plasmids
Start
site
Stop
site Description
5289 5645 Putative transposase subunit
12369 11653 Putative transposase subunit
12391 12669 Putative resolvase
12884 13207 Putative resolvase
13488 14390 Putative manganese-dependent inorganic
pyrophosphatase
16020 16448 Universal stress protein UspA
15085 14819 Hypothetical protein
15089 16117 Conserved hypothetical protein
49878 48862 Transposase protein for IS5
51219 51494 Conserved hypothetical protein
57018 58109 Replication protein RepC
58111 60336 Plasmid inhibition protein PifA
75811 76338 Putative resolvase
77713 78663 Putative replication protein
78971 79786 Putative replication protein
80052 79783 Hypothetical protein
82733 83206 Dihydrofolate reductase type I protein DhfrA1
83299 84090 Aminoglycoside resistance protein AadA
84254 84601 Quaternary ammonium compound resistance protein
QacEdelta1
84508 85434 Dihydropteroate synthase protein Sul1
85562 86062 Conserved hypothetical protein
87023 86238 Putative transposase protein IstB
88533 87010 Putative transposase protein IstA
89363 88635 Partial transposase protein TniB
90018 90734 Putative penicillin binding protein
91830 92252 Conserved hypothetical protein
92289 93128 Conserved hypothetical protein
93165 94073 Putative macrolide 2-phosphotransferase II
96268 94592 Partial transposase protein TniB
97977 96262 Putative transposase TniA
98900 98016 Conserved hypothetical protein
99336 98953 Mercury resistance operon transcriptional regulator
MerD
101027 99333 Mercury resistance operon mercuric reductase MerA
101540 101079 Mercury resistance operon transport protein MerC
101848 101537 Mercury resistance operon protein MerP
102230 101826 Mercury resistance operon mercuric transport
protein MerT
102601 102239 Conserved hypothetical protein
FIG. 3. Linear map of the MDR-encoding region of pAPEC-O103-ColBM. Dashed lines indicate potential evolutionary breakpoints identified
by nucleotide sequence comparisons and identified inverted repeats in the sequence. Nucleotide similarity (90%) with pSMS35_130 is indicated
below the scale (in base pairs).
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lator), filtered human urine, 90% filtered chicken serum, and
90%, 75%, or 50% filtered human serum (Table 3 and Fig. 4).
In LB broth, broth containing 400 M 2,2-dipyridyl, and
urine, the loss of pAPEC-O103-ColBM did not correlate with
attenuated growth. However, in 75 and 90% human serum, loss
of the plasmid resulted in a significantly lower survival rate
(P  0.05). Complementation of the cured strain with the
plasmid restored wild-type levels of growth in serum.
FIG. 4. Growth of bacterial strains in various growth media determined using OD600. Counts for an 18-h period are shown. Each strain was tested
in quadruplicate, and each experiment was performed twice on separate occasions. The data are averages for the experiments for each time point.
TABLE 3. Growth of ExPEC 408 and its derivatives in various media as determined using viable counts
Strain
Growth rate ina:
LB broth
(pH 7.0)
LB broth
(pH 5.0)
LB broth  400
M 2,2-
dipyridyl
90% Chicken
serum
75% Human
serum
90% Human
serum Human urine
APEC O1 0.76 0.51 0.29 0.78 0.04 0.10 NDb
APEC O2 ND ND ND ND ND ND 0.69
DH5 0.44 0.33 0.00 0.31 1 1 0.16
ExPEC 408 0.76 0.56 0.20c 0.75 0.15c 0.09c 0.66
408.1 0.75 0.57 0.18c 0.77 0.30d 0.22d 0.59
408.2 0.76 0.58 0.21c 0.74 0.13c 0.12c 0.63
a The growth rate was determined by calculating the slope of log-transformed data during exponential growth. Negative values reflect a decline in survival as
determined using viable counts.
b ND, not determined.
c Significantly different (P  0.05) than the value for the known positive control (APEC O1 or APEC O2) as determined using a two-tailed Student t test.
d Significantly different (P  0.05) than the value for the known positive control and ExPEC wild-type strain 408 as determined using a two-tailed Student t test.
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Contribution of pAPEC-O103-ColBM to the pathogenesis of
disease in multiple animal models. ExPEC 408 and its deriv-
atives were tested using several animal models of human and
avian disease. Two models of avian colibacillosis were tested.
In the chick models of avian colibacillosis, the plasmid-cured
strain showed attenuation of virulence compared to wild-type
strain and the plasmid-complemented strain (Table 4). The
differences in both the intratracheal and subcutaneous models
were statistically significant (P  0.05).
In the rat model of human bacteremia and meningitis,
ExPEC 408 caused both bacteremia and meningitis (Fig. 5).
The plasmid-cured strain was significantly attenuated com-
pared to the wild type and the complemented strain. The viable
counts of bacteria isolated from blood and CSF paralleled
these findings; most of the rats inoculated with the plasmid-
cured strain and the negative-control rats did not contain bac-
teria in their blood or CSF (Fig. 6), whereas the viable counts
for rats infected with the wild type and rats infected with the
complemented strain were similar. It is also interesting that the
viable counts for ExPEC 408 and the complemented strain in
the blood and CSF were approximately 10-fold less than the
viable counts for the positive-control strain, prototypic NMEC
strain RS218. The counts for these strains were about 100-fold
higher than those for the ExPEC 408 plasmid-cured derivative
(Fig. 6). A histopathology analysis was performed using brain
tissue from rats infected with ExPEC 408 or its derivatives
(Fig. 7). When wild-type ExPEC strain 408 and its plasmid-
complemented derivative were used, moderate diffuse menin-
gitis was observed, and neutrophils and lymphocytes were scat-
tered throughout the cerebral parenchyma and areas of mild
edema. The plasmid-cured strain did not produce any lesions.
ExPEC 408 and its derivative were also tested to determine
their abilities to adhere to and invade human BMECs in order
to model the ability to cross the blood-brain barrier. ExPEC
408 and its plasmid-complemented derivative adhered to and
invaded human BMECs at a significantly higher rate (P 0.05)
than the plasmid-cured derivative (Table 5). Again, the asso-
ciation and infectivity values for the wild-type and comple-
mented strains were lower than those for the archetypal strain
RS218 but higher than those for the plasmid-cured strain.
Decreased drug susceptibility conferred by pAPEC-O103-
ColBM. ExPEC 408 and its derivatives were also examined to
determine their susceptibilities to various antimicrobial agents
(Table 6). Using observed resistance phenotypes based on MICs
and disk diffusion results, pAPEC-O103-ColBM was found to
confer decreased susceptibilities to streptomycin (strAB), sulfisox-
azole (sul2 and sulI), tetracycline (tetAR), erythromycin (mphB),
and trimethoprim-sulfamethoxazole (sul2, sulI, and dhfrA1).
However, decreased susceptibility to ampicillin was not conferred
by pAPEC-O103-ColBM, suggesting that the penicillin binding
protein homolog is not active against this class of antimicrobial
agents.
Prevalence of ColV and ColBM plasmids in ExPEC. Using
markers for the ColV and ColBM operons and genes specific
for pAPEC-O103-ColBM, ExPEC populations were examined
to determine the prevalence of these plasmids (Table 7). High
percentages of the isolates in the APEC and NMEC popula-
tions contained a ColV or ColBM plasmid (66.7% and 58.2%,
respectively), whereas UPEC isolates generally lacked this
plasmid (5.2%). Of the isolates containing a ColV or ColBM
plasmid, nearly one-third contained a ColBM plasmid, and
approximately 15 to 16% of the ColV or ColBM plasmids
contained genes unique to pAPEC-O103-ColBM compared to
the other sequenced ColV and ColBM plasmids.
DISCUSSION
ColV and ColBM plasmids have been associated with a
variety of traits, including serum resistance (4), iron acquisition
(7, 48), resistance to chlorine and disinfectants (16), growth in
human urine (49), improved growth under acidic pH condi-
tions (40), bacteriophage resistance (18), establishment of
avian colibacillosis (49, 60), and establishment of septicemia
and urinary tract infections (2, 39). Here, a ColBM plasmid
was sequenced and analyzed because of its mosaic nature; it
contains both virulence-associated and drug resistance-associ-
ated genes. The ExPEC strain harboring this plasmid was iso-
lated from a peritonitis lesion in a commercial layer hen. In
subcutaneous and intratracheal models mimicking aspects of
FIG. 5. Average concentrations of bacteria in the blood and CSF of
rats infected with ExPEC 408 and its derivatives. The error bars indi-
cate the average results for two experimental trials, and at least 11 rats
were used for experimental group. An asterisk indicates that a value is
significantly different (P  0.05) from the value for ExPEC 408.
TABLE 4. Results for chick infection models of avian colibacillosis
Strain
Mean lesion score
for subcutaneous
modela
Mean lesion score
for intratracheal
modela
DH5 0b 0f
APEC O1 8.33c 7.08c
ExPEC 408 3.08d 3.50d
408.1 0.58e 0.17f
408.2 2.50d 2.33d
a The range of lesion scores was 0 to 10.
b Significantly different (P  0.05) than the scores for APEC O1, ExPEC 408,
408.1, and 408.2.
c Significantly different (P  0.05) than the scores for DH5, ExPEC 408,
408.1, and 408.2.
d Significantly different (P  0.05) than the scores for DH5, APEC O1, and
408.1.
e Significantly different (P  0.05) than the scores for DH5, APEC O1,
ExPEC 408, and 408.2.
f Significantly different (P  0.05) than the scores for APEC O1, ExPEC 408,
and 408.2.
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avian pathogenesis, ExPEC 408 cured of its plasmid was sig-
nificantly attenuated compared to the wild-type strain. As ob-
served for other avian E. coli strains belonging to more typi-
cally encountered serogroups, such as serogroups O2 and O78,
it appears that this serogroup O103 isolate owes much of its
virulence for birds to its plasmid.
In addition to contributing to avian disease, pAPEC-O103-
ColBM also contributed to disease in an animal model of
human septicemia and human meningitis. Surprisingly, curing
of pAPEC-O103-ColBM from its host did not affect the host’s
ability to grow in chicken serum, low-iron medium, or urine, as
previously described for the ColV and ColBM plasmids (33,
59). Perhaps this lack of a significant change in the phenotype
upon curing reflects the presence of redundant systems on
ExPEC 408’s chromosome and hints that ExPEC 408 is a
coincidental host in birds. Similarly, introduction of the plas-
FIG. 6. Percentages of animals in each experimental group in the rat model containing different concentrations of bacteria in (A) blood and
(B) CSF.
FIG. 7. Histopathology of rat brain tissue 18 h after inoculation of ExPEC wild-type strain 408 (A), ExPEC 408 cured of pAPEC-O103-ColBM
(B), and ExPEC 408 complemented with pAPEC-O103-ColBM (C). In panels A and C, moderate diffuse meningitis was observed (arrows), with
neutrophils and lymphocytes scattered throughout the cerebral parenchyma and mild areas of edema. There were similar inflammatory cells that
were scattered throughout the cerebral parenchyma and mild areas of edema (not shown). The plasmid-cured strain (B) (the lower magnification
shows a larger region) did not cause any lesions.
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mid into strain DH5 did not increase the ability of this strain
to grow in these media, suggesting that a certain chromosomal
background is required for this plasmid to exhibit its effects.
Despite its ability to cause disease in several models of infec-
tion or survival, ExPEC 408 lacked most the 49 ExPEC-asso-
ciated or virulence-associated genes examined here, including
some genes and/or operons associated with iron acquisition.
The absence of typical ExPEC chromosomal virulence factors
in ExPEC 408 was reflected by the fact that it belonged to the
B1 phylogenetic group (22). Thus, several possibilities could
account for ExPEC 408’s ability to cause disease. These in-
clude the possibility that there are as-yet-unidentified virulence
factors in ExPEC 408’s chromosome, the possibility that pA-
PEC-O103-ColBM carries known or novel virulence factors
that contribute to disease, or a combination of both. The latter
seems to be the most likely explanation. However, it is evident
from the results that pAPEC-O103-ColBM contributes to es-
tablishment of both human disease and avian disease.
Several studies have identified ColV plasmids in ExPEC
isolates obtained from the CSF of neonatal meningitis patients
(2, 10, 26, 39). However, these isolates belong to common
serogroups of NMEC strains, such as serogroups O18, O45,
and O7. Because these strains contain other essential NMEC
virulence factors, it has been difficult to elucidate the precise
role of the ColV and ColBM plasmids in establishment of
neonatal meningitis in isolates possessing other typical NMEC
virulence factors. ExPEC 408 belongs to the O103 serogroup,
a serogroup not known for its role in human neonatal menin-
gitis. ExPEC 408 also lacks the K1 capsule, the ibeA gene, S
fimbriae, and cnf1, all of which are chromosomal traits known
to be involved in translocation across the blood-brain barrier
(5). A ColV plasmid from an O45:K1 human isolate was re-
cently associated with the ability of ExPEC to establish septi-
cemia in the rat model (39). Here, a ColBM plasmid from an
avian isolate behaved similarly, but it was also found to con-
tribute to the overall establishment of meningitis and to con-
tribute to the adhesion and invasion of human BMECs. Since
many NMEC isolates appear to possess ColV or ColBM plas-
mids, it is possible that these plasmids play an important role
in establishment of human neonatal meningitis in some strains.
Certainly, studies have demonstrated a role for some ColV-
associated genes, such as iroN, in the invasion of extraintestinal
cell types (12). Further examination of our ExPEC collections
showed that NMEC isolates harbored ColV and ColBM plas-
mids at ratios very similar to those for APEC isolates (Table 7).
Certainly, there is evidence for a food-borne link between the
two groups (25). At the very least, it appears that at least some
NMEC isolates rely on these plasmid types for establishment
of septicemia and/or meningitis in the neonatal human host.
The hosts of pSMS35_130 and pAPEC-O103-ColBM were
isolated from environments where antimicrobial pressures were
likely to be present (14). The acquisition of MDR-encoding vir-
ulence plasmids by environmental strains is disturbing, since these
plasmids provide a means for MDR with apparently high concen-
trations and also provide selectable virulence. The resistance
mechanisms employed by pAPEC-O103-ColBM are typical of the
resistance mechanisms of bacterial isolates found in the poultry
environment (47). Interestingly, th MDR region described here
apparently evolved differently than that of pSMS35_130. While
the pSMS35_130 MDR-encoding region appears to have evolved
via integration of DNA into multiple IS26 “hotspots,” the MDR-
encoding region of pAPEC-O103-ColBM appears to have
evolved in a way more typical of F plasmids. For example,
pAPEC-O103-ColBM contains an In2-like element originally de-
scribed by Liebert et al., and this region alone confers resistance
to at least five antimicrobial agents (32). It appears that in this
region on pAPEC-O103-ColBM an interesting insertion occurred
via 12-bp inverted repeats, and this region contains a gene that
confers macrolide resistance but is largely uncharacterized. Fi-
nally, the entire In2 region appears to have been inserted in a
region sharing homology with the Salmonella enterica serovar
Typhimurium IncI1 plasmid R64 (GenBank accession no.
AP005147), since the sequence surrounding In2 shares homology
at both ends with plasmid R64, and this region is bounded by
transposable elements in pAPEC-O103-ColBM. Thus, pAPEC-
O103-ColBM appears to have undergone stepwise evolution in-
TABLE 7. Prevalence of ColV and ColBM plasmids in the
ExPEC subpathotypes
Plasmids
% of strains
APEC
(n 
 96)
NMEC
(n 
 91)
UPEC
(n 
 96)
ColV or ColBM type (hlyF, repA,
iss, iroN, cvaC, or cma)
66.7 58.2 5.2
ColBM type (hlyF, repA, iss,
iroN, or cma)
31.3 20.9 1
pAPEC-O103-ColBM type
harboring uspA (hlyF, repA, iss,
iroN, cma, or uspA)
16.7 15.4 2.1
TABLE 5. Association with and invasion of human BMECs by
ExPEC 408 and its derivatives
E. coli strain
% Association
based on total
number of cells
% Invasion compared
to invasion by RS218
NMEC RS218 5.6 100
ExPEC 408 12.4 21.3
408.1 7.7a 1.3a
408.2 12.1 24.7
a Significantly different (P 0.05) than the value for ExPEC 408, as calculated
with a two-tailed Student t test.
TABLE 6. Antimicrobial susceptibilities of ExPEC 408 and
its derivatives
Antibiotic
Susceptibility ofa:
ExPEC 408 408.1 DH5 408.3
Streptomycin R S S R
Tetracycline R I S R
Chloramphenicol S S S S
Gentamicin S S S S
Trimethoprim R R S I
Ampicillin I I S S
Nalidixic acid I I R R
Kanamycin I I S S
Sulfisoxazole R R S R
Rifampin S S S S
Erythromycin R S S R
a S, sensitive; R, resistant; I, intermediate.
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volving introduction of an MDR-encoding region that evolved via
multiple recombinational events.
In conclusion, we determined the sequence of an MDR-
encoding ColBM virulence plasmid from an avian ExPEC iso-
late and characterized this plasmid. This plasmid contributes to
the key steps in establishment of human neonatal meningitis
and avian colibacillosis, suggesting that it confers zoonotic
capabilities on its ExPEC host. ColV and ColBM plasmids
appear to be common in NMEC isolates, irrespective of the
presence of chromosome-encoded NMEC virulence factors.
The emergence of ExPEC strains with MDR and zoonotic
potential encoded by transmissible elements is alarming and
should prompt further efforts to prevent and control the dis-
semination of the plasmids conferring such abilities.
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